Tulane Cancer Center, Tulane University
Dr. Sartor has been a practicing oncologist since 1982 and is a cancer research scientist. Currently, he’s the assistant dean for oncology and the Bernadine Laborde Professor of Cancer research, medicine, and urology at the Tulane School of Medicine. In his long career, he’s published extensively, including more than 300 peer-reviewed articles, and he’s currently the editor-in-chief of the bimonthly journal of Clinical Genitourinary Cancer.
Why They Made the Worthy 100: Long service towards curing what many feel is an incurable disease aside; Sartor announced new developments in the treatment of prostate cancer in 2022. He and other scientists have moved to review the clinical use of PSMA agents in prostate cancer treatment.